| abstract |
The present invention provides an indirubin formulation that can increase solubility, bioavailability, improve clinical efficacy, reduce patient dose variability, and potentially reduce side effects. A nanoparticulate indirubin composition comprising particles of indirubin or a derivative thereof and at least one surface stabilizer for the treatment of cancer, neurodegenerative disorders and inflammatory diseases. Indirubin nanoparticles have an effective average particle size of less than 2 microns. [Selection figure] None |